Atom Investors’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-248,607
Closed -$674K 727
2025
Q4
$674K Buy
248,607
+145,391
+141% +$477K 0.05% 355
2025
Q3
$437K Buy
+103,216
New +$454K 0.03% 378
2022
Q1
Sell
-20,371
Closed -$666K 251
2021
Q4
$666K Sell
20,371
-66,649
-77% -$2.68M 0.11% 139
2021
Q3
$3.57M Sell
87,020
-36,239
-29% -$1.31M 0.29% 35
2021
Q2
$4.44M Buy
+123,259
New +$4.55M 0.56% 30
2020
Q4
Sell
-5,500
Closed -$306K 446
2020
Q3
$306K Buy
+5,500
New +$291K 0.03% 292

Other funds holding GDRX

Atom Investors's GDRX Position: Q1 2026 in Review

Atom Investors sold out of GoodRx Holdings (GDRX) in Q1 2026, closing a stake of 248,607 shares — an estimated $674K sold.

Atom Investors first reported a position in GDRX in Q3 2020 and held it in 6 quarters. The position peaked at $4.44M in Q2 2021. 176 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Atom Investors reported no remaining GoodRx Holdings position as of Q1 2026 after selling out during the quarter.
  • Atom Investors sold 248,607 GoodRx Holdings shares in Q1 2026, an estimated $674K.
  • Atom Investors first reported a position in GoodRx Holdings in Q3 2020 and held it in 6 quarters.
  • Atom Investors's GoodRx Holdings position peaked at $4.44M in Q2 2021.
  • 176 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Atom Investors's 13F filing for Q1 2026, filed 15 May 2026.